| |
| |
|
| Insider
Information: |
Vander Vort John |
| Relationship: |
10% Owner |
| City: |
Boston |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
8,333,609 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$95,298,898 |
|
|
| Total
Shares |
8,333,609 |
|
|
| Total
Value |
$95,298,898 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Pacira Pharmaceuticals, Inc. |
PCRX |
Former 10% Owner |
2013-03-11 |
0 |
2013-03-11 |
2,790,479 |
Premium* |
|
|
Aratana Therapeutics, Inc. |
PETX |
Director |
2019-07-18 |
0 |
2013-07-02 |
4,351,050 |
Premium* |
|
|
Histogen Inc |
HSTO |
10% Owner |
2013-07-30 |
0 |
2013-07-30 |
1,192,080 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
14 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PETX |
Aratana Therapeutics, Inc... |
Director |
– • – |
2019-07-18 |
4 |
D |
$0.00 |
$0 |
D/D |
(43,000) |
0 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Director |
– • – |
2019-06-06 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
43,000 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Director |
– • – |
2018-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
38,500 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Director |
– • – |
2017-06-21 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
34,000 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Director |
– • – |
2016-06-24 |
4 |
A |
$0.00 |
$0 |
D/D |
4,500 |
29,500 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Director |
– • – |
2015-03-06 |
4 |
AS |
$20.01 |
$122,776 |
D/D |
(6,137) |
25,000 |
0 |
- |
|
| HSTO |
Histogen Inc |
10% Owner |
– – • |
2013-07-30 |
4 |
B |
$11.00 |
$1,817,915 |
I/I |
165,265 |
1,192,080 |
1.5 |
- |
|
| HSTO |
Histogen Inc |
10% Owner |
– – • |
2013-07-30 |
4 |
A |
$11.00 |
$183,876 |
I/I |
16,716 |
1,026,815 |
0 |
- |
|
| HSTO |
Histogen Inc |
10% Owner |
– – • |
2013-07-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,010,099 |
1,010,099 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Director |
– • • |
2013-07-02 |
4 |
B |
$6.00 |
$3,000,000 |
I/I |
500,000 |
4,351,050 |
2.25 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Director |
– • • |
2013-07-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,434,616 |
3,851,050 |
0 |
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Director |
– • • |
2013-06-26 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
24,067 |
|
- |
|
| PETX |
Aratana Therapeutics, Inc... |
Director |
– • • |
2013-06-26 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
180,505 |
|
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Former 10% Owner |
– – – |
2013-03-11 |
4 |
S |
$27.86 |
$13,930,000 |
I/I |
(500,000) |
2,790,479 |
0 |
- |
|
14 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
